Skip navigation

Teva Pharmaceutical Industries Ltd.

Pharmaceuticals
Israel
2016 Revenue (US$ Millions)$21,903
Revenue Growth (%)11.45%
Net Income (US$ Millions)$329
Earnings Per Share (US$)$0.07
EPS Growth Rate (%)-96.15%
Profit Margin1.50%
Total Equity (US$ Millions)$33,337
Return on Equity (%)1.11%
Long Term Debt (US$ Millions)$32,524
Debt To Equity Ratio (%)0.98%
Total Assets (US$ Millions)$92,890
Current Assets (US$ Millions)$16,961
Current Liabilities (US$ Millions)$18,519
Cost of Goods Sold (US$ Millions)$10,044
Inventory Turnover2.25